Clinical Trial 44118

Culver City, CA 90230


Summary:

Participate in a Schizophrenia Trial Without Discontinuing Current Treatment

    If you or someone you love are living with schizophrenia, you may qualify for a clinical research trial testing the efficacy and safety of CTP-692, an investigational medication working as an adjunctive treatment. Adjunctive therapies work with your current treatment regimen, meaning you do not have to give up your current treatment options.

    You or your loved one may qualify for participation if you/they:

    • Are between the ages of 18 and 55.
    • Have a physician-confirmed DSM-V diagnosis of schizophrenia.
    • Are already taking one antipsychotic medication.

    You or your loved one may not qualify for participation if you/they:

    • Are currently taking clozapine.
    • Have moderate to severe drug or alcohol substance use disorder in the past 6 months.
      • Please note, this does not include caffeine or nicotine.
    • Have a history of renal disease.

    Additional study requirements and exclusions may apply. A study representative will discuss these with you during the screening period.


    Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.